← All organizations

Kettering Health Network

Academic/HospitalWebsite ↗

Also known as: Harvey Hahn | Kettering Health Network | KETTERING MEDCTR

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

First marketed drug

Last known activity

Feb 2, 2019

Timeline

1990s

Jan 1, 1999
Kettering Health Network— Founded

2010s

Oct 27, 2015
fludeoxyglucose f-18— Marketing Organization

Drugs by trial phase (12 distinct, 8 trials)

Phase 4 (9 own, 0 via acquisition)

Phase 2 (2 own, 0 via acquisition)

Other trials (1 own, 0 via acquisition)

platelets

Indications

Studied for

Marketed drugs (1)

fludeoxyglucose f-18

Recent trials (14)

NCT03995641Lead sponsorPhase 4Feb 2, 2019
NCT03995641Reponsible party - principal investigatorPhase 4Feb 2, 2019
NCT03196310Lead sponsorN/AAug 1, 2017
NCT02412852CollaboratorPhase 2May 1, 2015
NCT02287675Lead sponsorPhase 4Oct 1, 2014
NCT02287675Overall official - principal investigatorPhase 4Oct 1, 2014
NCT02244619Lead sponsorPhase 4Sep 1, 2014
NCT02244619Overall official - principal investigatorPhase 4Sep 1, 2014
NCT01767987Sponsor investigatorPhase 2Nov 1, 2012
NCT01767987Overall official - principal investigatorPhase 2Nov 1, 2012
NCT01767987Lead sponsorPhase 2Nov 1, 2012
NCT00781482Lead sponsorPhase 4Oct 27, 2008
NCT00781482Overall official - principal investigatorPhase 4Oct 27, 2008
NCT00712270Lead sponsorPhase 4Apr 1, 2005

Details

Founded: Dayton, OH, US Jan 1, 1999
Last known activity: Feb 2, 2019